Year end inventory: 7 kinds of heavy-duty generic drugs that have been listed and approved in 2019

Generic drugs refer to non original drugs that only copy the main components of the original drugs According to nmpa data, the number of generic drugs approved in 2019 in China is 147, including 14 approved by Zhengda Tianqing, 12 approved by Qilu, 9 approved by Yangzijiang, 9 approved by Kelun, 8 approved by Fuxing and 8 approved by China Resources Sangeshi summarized the heavyweight generic drugs as follows: Manufacturer: Zhengda Tianqing; Qilu pharmaceutical Listing time: September 26, 2019; October 23, 2019 Indications: it is used to treat adult patients with moderate to severe active rheumatoid arthritis, psoriatic arthritis and ulcerative colitis with insufficient or intolerant response to methotrexate Manufacturer: Zhengda Tianqing; Qilu pharmaceutical Listing time: January 9, 2019; April 25, 2019 Indications: in combination with dexamethasone, for adult patients with multiple myeloma who have received at least one treatment Manufacturer: Zhengda Tianqing; Hunan Kelun; Qilu pharmaceutical Listing time: May 15, 2019; December 6, 2019; December 23, 2019 Indications: it is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer that has received chemotherapy before Manufacturer: Chengdu Shengdi; Zhengda Tianqing; Jiangxi Shanxiang Listing time: July 4, 2019; July 12, 2019; September 17, 2019 Indications: treatment of metastatic castration resistant prostate cancer Manufacturer: Zhengda Tianqing Listing time: August 2, 2019 Indication: 1 It is used in adult patients undergoing selective hip or knee replacement to prevent venous thrombosis (VTE) 2 For the treatment of adult venous thrombosis (DVT), reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT 3 For adults with one or more risk factors of nonvalvular atrial fibrillation to reduce the risk of stroke and systemic embolism Manufacturer: Jiangsu Haosen, Zhengda Tianqing, Sichuan Kelun Listing time: January 9, 2019; May 5, 2019; November 4, 2019 Indication: it is used to prevent thrombus in patients who have undergone hip or knee replacement Manufacturer: Sichuan Huiyu; Zhengda Tianqing